InsidersTradesSigma
Follow the コスモ・バイオ株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, コスモ・バイオ株式会社 has published 11 insider filings. Market capitalisation: €7.1bn. The latest transaction was filed on 18 November 2025 (Holding update). Among the most active insiders: Hikari Tsushin K.K.. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
14Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,511 of 29,055 companies
58.4
score / 100
Value60
Quality56
FCF yld4.4%
Earn yld4.7%
EV/EBITDA10.7x
ROE3.6%
Gross mgn34%
Net mgn3.1%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 November 2025
Declarations11 total
1.2% of flowShareXTKSEDINET:S100X2OH
1.2% of flowShareXTKSEDINET:S100WQFK
11.1% of flowShareXTKSEDINET:S100U5ET
10.2% of flowShareXTKSEDINET:S100TL6M
10.6% of flowShareXTKSEDINET:S100T6U4
10.9% of flowShareXTKSEDINET:S100STUL
11.0% of flowShareXTKSEDINET:S100SIZ5
10.9% of flowShareXTKSEDINET:S100S3F6
11.1% of flowShareXTKSEDINET:S100RD74
53.4% of flowShareXTKSEDINET:S100QB71
46.6% of flowShareXTKSEDINET:S100PT6R
11 of 11 declarations
关于 コスモ・バイオ株式会社
Cosmo Bio Co., Ltd. 是一家日本公司，专注于健康和制药领域。该公司在 XTKS 市场上市。